Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 4/20 | 0.42 |
| ▸ | PHGDH | O43175 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5667904 | 0.87 | TRPA1 (0.50) | TRPA1CNR2PHGDHCTSLCTSS | |
| SCHEMBL5669522 | 0.77 | ALDH1A1 (0.42) | TRPA1CNR2PHGDH | |
| SCHEMBL5667849 | 0.77 | MEN1 (0.50) | TRPA1PHGDH | |
| SCHEMBL7199912 | 0.75 | CASP3 (0.45) | TRPA1PHGDH | |
| SCHEMBL5494468 | 0.75 | CTSD (0.51) | CTSLCTSSREN | |
| SCHEMBL5667638 | 0.75 | CNR2 (0.51) | TRPA1CNR2 | |
| SCHEMBL5667918 | 0.73 | TRPA1 (0.51) | TRPA1CNR2PHGDHCTSLCTSS | |
| SCHEMBL7204508 | 0.73 | CASP3 (0.40) | CNR2 | |
| SCHEMBL7387938 | 0.72 | TRPA1 (0.49) | TRPA1CNR2PHGDHCTSLCTSS | |
| SCHEMBL5174682 | 0.72 | REN (0.39) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030039661-A1 | Methods, compositions and kits for preserving antigenicity | IDUN PHARMACEUTICALS, INC. | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030039661-A1 | Methods, compositions and kits for preserving antigenicity | CASP1, CASP3, APAF1 | TRPA1 4435/4885CNR2 4542/4885PHGDH 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.